Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06285175 · ClinicalTrials.gov registry record · NA
REINVENT: A Brain and Muscle Computer Interface for Stroke
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06285175 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 14 participants.
The verdict
NCT06285175, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Stroke is a leading cause of adult disability in the United States. High doses of repeated task-specific practice have shown promising results in restoring upper limb function in chronic stroke (\>6 months after onset). However, it is currently challenging to provide such doses in standard clinical practice. At-home telerehabilitation services supervised by a clinician are a potential solution to provide higher-dose interventions. However, telerehabilitation systems developed for repeated task-specific practice typically require a minimum level of active movement. Therefore, severely impaired people necessitate alternative therapeutic approaches. Measurement and feedback of electrical muscle activity via electromyography (EMG) have been previously implemented in the presence of minimal or no volitional movement to improve motor performance in people with stroke. Specifically, muscle neurofeedback training to reduce unintended co-contractions of the impaired hand may be a targeted intervention to improve motor control in severely impaired populations. In this study, we examine the effects of a low-cost, portable, and modular EMG biofeedback system (Tele-REINVENT) for supervised and unsupervised upper limb telerehabilitation after stroke during a 6-week home-based training program that reinforces activity of the wrist extensor muscles while avoiding coactivation of flexor muscles via computer games.
Interventions
- OTHER Tele-REINVENT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06285175
The ClinicalTrials.gov registry entry for NCT06285175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tele-REINVENT is the first listed.
NCT06285175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06285175 about?
NCT06285175 is a clinical study titled "REINVENT: A Brain and Muscle Computer Interface for Stroke". Stroke is a leading cause of adult disability in the United States. High doses of repeated task-specific practice have shown promising results in restoring upper limb function in chronic stroke (\>6 months after onset). However, it is currently challenging to provide such doses in standard clinical ...
What is the current status of trial NCT06285175?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-06-01. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT06285175?
The interventions under investigation include: Tele-REINVENT (OTHER).
Who is sponsoring clinical trial NCT06285175?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.